Pratishtha Chatterjee

3.0k total citations · 2 hit papers
42 papers, 1.5k citations indexed

About

Pratishtha Chatterjee is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Pratishtha Chatterjee has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 18 papers in Psychiatry and Mental health and 8 papers in Molecular Biology. Recurrent topics in Pratishtha Chatterjee's work include Alzheimer's disease research and treatments (25 papers), Dementia and Cognitive Impairment Research (13 papers) and Tryptophan and brain disorders (5 papers). Pratishtha Chatterjee is often cited by papers focused on Alzheimer's disease research and treatments (25 papers), Dementia and Cognitive Impairment Research (13 papers) and Tryptophan and brain disorders (5 papers). Pratishtha Chatterjee collaborates with scholars based in Australia, United States and United Kingdom. Pratishtha Chatterjee's co-authors include Ralph N. Martins, Hamid R. Sohrabi, Kathryn Goozee, Kevin Taddei, Steve Pedrini, Prita R. Asih, Kaj Blennow, Henrik Zetterberg, Victor L. Villemagne and Preeti Dave and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Molecular Psychiatry.

In The Last Decade

Pratishtha Chatterjee

42 papers receiving 1.5k citations

Hit Papers

Plasma glial fibrillary acidic protein is elevated in cog... 2021 2026 2022 2024 2021 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
    2021 276 citations Pratishtha Chatterjee, Steve Pedrini et al. Translational Psychiatry profile →
  2. Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
    2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pratishtha Chatterjee Australia 18 806 487 427 271 220 42 1.5k
Tejal Shah Australia 21 693 0.9× 216 0.4× 452 1.1× 154 0.6× 115 0.5× 52 1.6k
Eve H. Pickering United States 21 749 0.9× 263 0.5× 601 1.4× 177 0.7× 197 0.9× 29 1.6k
Aaron Koenig United States 13 802 1.0× 284 0.6× 431 1.0× 317 1.2× 123 0.6× 26 1.8k
M. Florencia Iulita Canada 26 969 1.2× 390 0.8× 554 1.3× 503 1.9× 203 0.9× 47 2.2k
Niki S.M. Schoonenboom Netherlands 22 1.3k 1.6× 1.0k 2.1× 435 1.0× 530 2.0× 123 0.6× 37 2.1k
D. Larry Sparks United States 22 1.2k 1.4× 291 0.6× 419 1.0× 909 3.4× 167 0.8× 41 2.4k
Laila Abdullah United States 34 1.0k 1.3× 596 1.2× 1.1k 2.6× 439 1.6× 113 0.5× 90 2.9k
Andrew S. Murtishaw United States 10 875 1.1× 165 0.3× 520 1.2× 575 2.1× 341 1.6× 17 1.8k
Eugene Hone Australia 18 760 0.9× 277 0.6× 380 0.9× 145 0.5× 62 0.3× 37 1.3k

Countries citing papers authored by Pratishtha Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Pratishtha Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pratishtha Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pratishtha Chatterjee more than expected).

Fields of papers citing papers by Pratishtha Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pratishtha Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pratishtha Chatterjee. The network helps show where Pratishtha Chatterjee may publish in the future.

Co-authorship network of co-authors of Pratishtha Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Pratishtha Chatterjee. A scholar is included among the top collaborators of Pratishtha Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pratishtha Chatterjee. Pratishtha Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eratne, Dhamidhu, Qiao-Xin Li, Courtney Lewis, et al.. (2024). Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort. Journal of Neurology. 272(1). 25–25. 4 indexed citations
2.
Yang, Yue, Woojin S. Kim, Simon J.G. Lewis, et al.. (2023). Predicting neurodegeneration from sleep related biofluid changes. Neurobiology of Disease. 190. 106369–106369. 4 indexed citations
3.
Asih, Prita R., Sina Shadfar, Pratishtha Chatterjee, et al.. (2023). Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer’s disease. Frontiers in Neuroscience. 17. 1297984–1297984. 13 indexed citations
4.
Pedrini, Steve, James D. Doecke, Eugene Hone, et al.. (2022). Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. Journal of Neurochemistry. 163(1). 53–67. 13 indexed citations
5.
Jacobs, Kelly R., Paul Maruff, Alan Rembach, et al.. (2022). Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β. Neurobiology of Disease. 171. 105783–105783. 11 indexed citations
6.
Pedrini, Steve, Pratishtha Chatterjee, Akinori Nakamura, et al.. (2022). The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults. Frontiers in Aging Neuroscience. 14. 771214–771214. 11 indexed citations
7.
Chatterjee, Pratishtha, Steve Pedrini, Erik Stoops, et al.. (2021). Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Translational Psychiatry. 11(1). 27–27. 276 indexed citations breakdown →
8.
Lim, Wei Ling Florence, Kevin Huynh, Pratishtha Chatterjee, et al.. (2020). Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer’s Disease. Journal of Alzheimer s Disease. 76(1). 303–315. 22 indexed citations
9.
Chatterjee, Pratishtha, Maryam Mohammadi, Kathryn Goozee, et al.. (2020). Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load. Journal of Alzheimer s Disease. 76(1). 291–301. 7 indexed citations
10.
Pedrini, Steve, Eugene Hone, Veer Bala Gupta, et al.. (2020). Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer s Disease. 77(2). 733–744. 10 indexed citations
11.
Chatterjee, Pratishtha, Cintia B. Dias, Tejal Shah, et al.. (2020). Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease. Mechanisms of Ageing and Development. 186. 111209–111209. 72 indexed citations
12.
Ashraf, Azhaar, Nicholas J. Ashton, Pratishtha Chatterjee, et al.. (2020). Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology. Alzheimer s Research & Therapy. 12(1). 72–72. 25 indexed citations
13.
Chatterjee, Pratishtha, Henrik Zetterberg, Kathryn Goozee, et al.. (2019). Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease. Journal of Neuroinflammation. 16(1). 186–186. 52 indexed citations
14.
Jacobs, Kelly R., Chai K. Lim, Kaj Blennow, et al.. (2019). Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau. Neurobiology of Aging. 80. 11–20. 97 indexed citations
15.
Chatterjee, Pratishtha, Kathryn Goozee, Chai K. Lim, et al.. (2018). Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study. Scientific Reports. 8(1). 8008–8008. 44 indexed citations
16.
Golzan, Mojtaba, Kathryn Goozee, Dana Georgevsky, et al.. (2017). Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease. Alzheimer s Research & Therapy. 9(1). 13–13. 83 indexed citations
17.
Shah, Tejal, et al.. (2017). Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease. Molecular Psychiatry. 22(3). 353–363. 46 indexed citations
18.
Muenchhoff, Julia, Anne Poljak, Anbupalam Thalamuthu, et al.. (2016). Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease. Scientific Reports. 6(1). 29078–29078. 36 indexed citations
19.
Chatterjee, Pratishtha, Veer Bala Gupta, Anne M. Fagan, et al.. (2015). Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer’s Disease: Baseline Data from a DIAN Cohort Subset. Current Alzheimer Research. 12(2). 157–164. 10 indexed citations
20.
Anil, M.H., et al.. (1987). Effects of intraportal infusion of glucose and lysine on food intake in intact and hepatic-vagotomized chickens. Appetite. 9(1). 65–72. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tejal Shah Breakdown of academic impact, for papers by Eve H. Pickering Breakdown of academic impact, for papers by Aaron Koenig Breakdown of academic impact, for papers by M. Florencia Iulita Breakdown of academic impact, for papers by Niki S.M. Schoonenboom Breakdown of academic impact, for papers by D. Larry Sparks Breakdown of academic impact, for papers by Laila Abdullah Breakdown of academic impact, for papers by Andrew S. Murtishaw Breakdown of academic impact, for papers by Eugene Hone
Rankless by CCL
2026